Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.

about

Colorectal Cancers: An Update on Their Molecular Pathology.Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system'.

P2860

Q48182864-7D23B795-CD95-49BB-9212-B0D444A91402 Q49560837-45D682D0-C7E1-4761-BF56-21F4A52EEE5A

P2860

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.

Item

http://www.wikidata.org/entity/Q40198390

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Association between mutations ...... location in colorectal cancer.

@en

type

Item

label

Association between mutations ...... location in colorectal cancer.

@en

prefLabel

Association between mutations ...... location in colorectal cancer.

@en

P1476

Association between mutations ...... location in colorectal cancer

@en

P2093

Dae-Won Lee

http://www.w3.org/2001/XMLSchema#string

Duhee Bang

http://www.w3.org/2001/XMLSchema#string

Hoon Jang

http://www.w3.org/2001/XMLSchema#string

Hwang-Phill Kim

http://www.w3.org/2001/XMLSchema#string

Hyojun Han

http://www.w3.org/2001/XMLSchema#string

Hyoki Kim

http://www.w3.org/2001/XMLSchema#string

Iksoo Huh

http://www.w3.org/2001/XMLSchema#string

Jaemyun Lyu

http://www.w3.org/2001/XMLSchema#string

Jeong Mo Bae

http://www.w3.org/2001/XMLSchema#string

Kyu Joo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

dbSNP: the NCBI database of genetic variation

Comprehensive molecular characterization of human colon and rectal cancer

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

P304

3513-3523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.30760

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28513830

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.

about

P2860

P2860

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921